Aurobindo Pharma Ltd. (AUROPHARMA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 164981, "name": "Aurobindo Pharma", "stock_name": "Aurobindo Pharma", "full_name": "Aurobindo Pharma Ltd.", "name_url": "stocks-analysis/aurobindo-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,697.00", "chg": -20.2, "chgp": "-1.18%", "dir": -1, "prev_price": "1,717.20", "mcapval": "98,223.00 Cr", "mcap": "Mid Cap", "scripcode": 524804, "symbol": "AUROPHARMA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE406A01037", "curr_date": "Sep 22, 03:30 PM", "curr_time": "00:34 AM", "last_traded_at": "Sep 22, 03:30 PM IST", "bse_nse_vol": "8.79 lacs", "exc_status": "Active", "traded_date": "Sep 22, 2026", "traded_date_str": "2026 09 22", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aurobindo-pharma-164981-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Aurobindo Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-sharp-open-interest-surge-amid-mixed-market-signals-4200091", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AurobindoPharma_oi_spurts_by_underlying_4200091.png", "date": "2026-09-21 15:00:06", "description": "Aurobindo Pharma Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased market participation and potential shifts in investor positioning. Despite a modest decline in the stock price, the underlying activity in futures and options suggests evolving directional bets that merit close attention from market participants." }, { "title": "Aurobindo Pharma Sees Significant Open Interest Surge Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-significant-open-interest-surge-amid-mixed-market-signals-4200043", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AurobindoPharma_oi_spurts_by_underlying_4200043.png", "date": "2026-09-21 14:00:07", "description": "Aurobindo Pharma Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.7% surge in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite this, the stock underperformed its sector and closed marginally lower, raising questions about the directional bets underpinning this spike in open interest." }, { "title": "Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1739", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-hits-new-52-week-high-at-rs1739-4199823", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AurobindoPharma_priceRelatedfactors_4199823.png", "date": "2026-09-21 10:10:48", "description": "Surging to a fresh 52-week and all-time high of Rs 1739 on 21 Sep 2026, Aurobindo Pharma Ltd. has demonstrated remarkable price momentum, outperforming the broader market by a significant margin over the past year. This milestone caps a 54.49% rally from its 52-week low of Rs 1066, underscoring the stock’s sustained technical strength amid a mixed market backdrop." }, { "title": "Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1707.9", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-hits-new-52-week-high-of-rs17079-on-18-sep-2026-4197685", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AurobindoPharma_priceRelatedfactors_4197685.png", "date": "2026-09-18 15:35:10", "description": "Surging past its previous peaks, Aurobindo Pharma Ltd. reached a new 52-week high of Rs 1707.9 on 18 Sep 2026, marking a remarkable 53.7% gain over the past year. This rally stands in stark contrast to the broader market, with the Sensex down 10.5% over the same period, underscoring the stock’s strong momentum despite a challenging environment." }, { "title": "Aurobindo Pharma Ltd. is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/aurobindo-pharma-ltd-is-rated-hold-by-marketsmojo-4193266", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AurobindoPharma_mojoScore_4193266.png", "date": "2026-09-15 10:10:51", "description": "Aurobindo Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 May 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 15 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Aurobindo Pharma Gains 0.20%: 4 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-gains-020-4-key-factors-driving-the-weeks-momentum-4192211", "imagepath": "", "date": "2026-09-13 15:00:41", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>31 Aug:</strong> New 52-week high at Rs.1,692.00</p>\n <p><strong>1 Sep:</strong> All-time high reached Rs.1,706.7</p>\n <p><strong>1 Sep:</strong> Sharp open interest surge amid mixed price signals</p>\n <p><strong>4 Sep:</strong> Week closes at Rs.1,653.30 (+0.20%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,650.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,653.30</div><div class=\"stat-change positive\">+0.20%</div..." }, { "title": "Aurobindo Pharma Ltd. is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/aurobindo-pharma-ltd-is-rated-hold-by-marketsmojo-4182386", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AurobindoPharma_mojoScore_4182386.png", "date": "2026-09-04 10:10:46", "description": "Aurobindo Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 September 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Aurobindo Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-sharp-open-interest-surge-amid-mixed-market-signals-4177979", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AurobindoPharma_oi_spurts_by_underlying_4177979.png", "date": "2026-09-01 12:00:07", "description": "Aurobindo Pharma Ltd. has witnessed a significant 21.6% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock underperformed its sector and traded in a narrow range close to its 52-week high, reflecting a complex interplay of bullish and cautious sentiments among traders." }, { "title": "Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1706.7", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-hits-new-52-week-high-at-rs17067-4177322", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AurobindoPharma_priceRelatedfactors_4177322.png", "date": "2026-09-01 09:35:33", "description": "With a remarkable 64.8% gain over the past year, Aurobindo Pharma Ltd. surged to a fresh 52-week high of Rs 1706.7 on 1 Sep 2026, outpacing the Sensex which declined by 4.2% over the same period. This milestone underscores the stock’s sustained momentum amid a broader market that has been under pressure." } ], "total": 868, "sid": "164981", "stock_news_url": "https://www.marketsmojo.com/news/aurobindo-pharma-164981" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "21-Sep-2026", "details": "Intimation of investor Analyst meet scheduled on 24.09.2026.", "source": "BSE" }, { "caption": "Completion Of US FDA Inspection At Unit-II Of Apitoria Pharma Private Limited A Wholly Owned Subsidiary Of The Company", "datetime": "15-Sep-2026", "details": "Submission of completion of US FDA inspection of Unit-II of Apitoria Pharma Private Limited a wholly owned subsidiary of the Company.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "15-Sep-2026", "details": "Submission of Press Release that is being issued in connection with receipt of US FDA final approval for Beclomethasone Dipropionate HFA Inhalation Aerosol 40 mcg and 80 mcg.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Aurobindo Pharma Ltd. has declared <strong>400%</strong> dividend, ex-date: 08 Aug 25", "dt": "2025-08-08", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Aurobindo Pharma Ltd. has announced <strong>1:5</strong> stock split, ex-date: 10 Feb 11", "dt": "2011-02-10", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Aurobindo Pharma Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 20 Jul 15", "dt": "2015-07-20", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

31 Aug: New 52-week high at Rs.1,692.00

1 Sep: All-time high reached Rs.1,706.7

1 Sep: Sharp open interest surge amid mixed price signals

4 Sep: Week closes at Rs.1,653.30 (+0.20%)

+0.20%Read full news article

Aurobindo Pharma Ltd. is Rated Hold by MarketsMOJO

2026-09-04 10:10:46

Aurobindo Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 September 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Aurobindo Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-09-01 12:00:07

Aurobindo Pharma Ltd. has witnessed a significant 21.6% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock underperformed its sector and traded in a narrow range close to its 52-week high, reflecting a complex interplay of bullish and cautious sentiments among traders.

Read full news article

Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1706.7

2026-09-01 09:35:33

With a remarkable 64.8% gain over the past year, Aurobindo Pharma Ltd. surged to a fresh 52-week high of Rs 1706.7 on 1 Sep 2026, outpacing the Sensex which declined by 4.2% over the same period. This milestone underscores the stock’s sustained momentum amid a broader market that has been under pressure.

Read full news article